JP2004530635A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530635A5
JP2004530635A5 JP2002537256A JP2002537256A JP2004530635A5 JP 2004530635 A5 JP2004530635 A5 JP 2004530635A5 JP 2002537256 A JP2002537256 A JP 2002537256A JP 2002537256 A JP2002537256 A JP 2002537256A JP 2004530635 A5 JP2004530635 A5 JP 2004530635A5
Authority
JP
Japan
Prior art keywords
noxi
nac
shows
phosphorylation
jnk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002537256A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530635A (ja
Filing date
Publication date
Priority claimed from GB0026254A external-priority patent/GB2368339B/en
Application filed filed Critical
Publication of JP2004530635A publication Critical patent/JP2004530635A/ja
Publication of JP2004530635A5 publication Critical patent/JP2004530635A5/ja
Pending legal-status Critical Current

Links

Images

JP2002537256A 2000-10-26 2001-10-25 多成分抗酸化性化合物、該化合物を含有する薬学的組成物、および酸化的ストレスを軽減または防止するためのそれらの使用 Pending JP2004530635A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0026254A GB2368339B (en) 2000-10-26 2000-10-26 Complex incorporating a plurality of antioxidants
PCT/IL2001/000984 WO2002034202A2 (en) 2000-10-26 2001-10-25 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress

Publications (2)

Publication Number Publication Date
JP2004530635A JP2004530635A (ja) 2004-10-07
JP2004530635A5 true JP2004530635A5 (cg-RX-API-DMAC7.html) 2005-04-21

Family

ID=9902037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002537256A Pending JP2004530635A (ja) 2000-10-26 2001-10-25 多成分抗酸化性化合物、該化合物を含有する薬学的組成物、および酸化的ストレスを軽減または防止するためのそれらの使用

Country Status (8)

Country Link
US (3) US20070287662A1 (cg-RX-API-DMAC7.html)
EP (1) EP1333809A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004530635A (cg-RX-API-DMAC7.html)
AU (1) AU2002212661A1 (cg-RX-API-DMAC7.html)
CA (1) CA2427005A1 (cg-RX-API-DMAC7.html)
GB (1) GB2368339B (cg-RX-API-DMAC7.html)
IL (2) IL155497A0 (cg-RX-API-DMAC7.html)
WO (1) WO2002034202A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
WO2003026684A1 (en) * 2001-09-27 2003-04-03 The Mental Health Research Institute Of Victoria Modulation of physiological processes and agents useful for same
US20060211628A1 (en) * 2002-08-02 2006-09-21 Daphne Atlas Treatment of multiple sclerosis with brain targeted anti oxidant compounds
AU2004293477A1 (en) 2003-11-25 2005-06-09 University Of Rochester Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
US8895032B2 (en) 2009-03-27 2014-11-25 Central Michigan University Dendritic nano-antioxidants
DK2493296T3 (en) 2009-10-30 2019-04-15 Retrotope Inc REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES
AU2012208283B2 (en) 2011-01-20 2017-01-05 Oneday - Biotech And Pharma Ltd. Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
US10058522B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Oxidative retinal diseases
US10154983B2 (en) * 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
KR102020579B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
WO2012148929A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Disorders implicating pufa oxidation
WO2014016831A1 (en) 2012-07-23 2014-01-30 Oneday - Biotech And Pharma Ltd. Glutathione-elevating compositions and uses thereof
EP2877194A4 (en) * 2012-07-25 2016-03-16 Oneday Biotech And Pharma Ltd Compositions and methods for increasing carnitine concentration in muscle tissue
WO2016009341A1 (en) 2014-07-14 2016-01-21 Radikal Therapeutics Inc. Thioredoxin mimetic prodrugs and uses thereof
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
EP4107163A4 (en) 2020-02-21 2024-06-19 Retrotope, Inc. PROCESSES FOR ISOTOPIC MODIFICATION OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
US11491130B2 (en) 2021-02-05 2022-11-08 Retrotope, Inc. Methods of treating amyotrophic lateral sclerosis
WO2026163188A1 (en) * 2025-01-31 2026-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Antiepileptic drugs and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738841A (en) * 1985-08-28 1988-04-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
KR0141693B1 (ko) * 1988-08-12 1998-06-15 나까무라 하루후미 펩티드 유도체 및 항치매제
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
IT1243911B (it) * 1990-11-19 1994-06-28 Zambon Spa Composizioni per la terapia mucolitica
US5464825A (en) * 1991-03-14 1995-11-07 Cornell Research Foundation, Inc. Raising glutathione equivalent levels using N-acyl glutathione monoesters
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
US5869615A (en) * 1994-01-03 1999-02-09 Washington University Modified complement proteases
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
SE9503679D0 (sv) * 1995-10-20 1995-10-20 Pharmacia Ab Antioxidants
US5744593A (en) * 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
AU3643497A (en) * 1996-06-28 1998-01-21 National Jewish Center For Immunology And Respiratory Medicine Use of thioredoxin-like molecules for induction of mnsod to treat oxidative damage
US5874468A (en) * 1996-12-26 1999-02-23 Yissum Brain targeted low molecular weight hydrophobic antioxidant compounds
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
WO1999050286A2 (en) 1998-03-31 1999-10-07 University Of Cincinnati Antioxidant peptides derived from apolipoprotein a-iv
US6686443B1 (en) * 2000-05-26 2004-02-03 The Regents Of The University Of California Chemical reagents for formation of disulfide bonds in peptides
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress

Similar Documents

Publication Publication Date Title
JP2004538039A5 (cg-RX-API-DMAC7.html)
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
DK1476185T3 (da) Antistoffer mod CD40
NO20053115D0 (no) Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
NO20040084L (no) Peptid-baserte forbindelser
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
PL368370A1 (pl) Kompozycja glifosatu
EP1542721A4 (en) MODIFIED "S" ANTIBODIES
DE50205853D1 (de) Drosselklappenstutzen
ATE326467T1 (de) Imidazo 1,2-aöpyridine
NO20031319D0 (no) Fremgangsmåte for fremstilling av N-(substituert fenyl)-3- alkyl-, aryl- ogheteroaryl-sulfonyl-2-hydroksy-2-alkyl- oghalogenalkylpropanamidforbindelser
IS7609A (is) 2,5-tvíútskipt 3-merkaptópentansýra
NO20041378L (no) [[2-(Amino-3,4-diokso-1-cyklobuten-1-yl)amino]alkyl]-syrederivater for behandling av smerte
NO20042214D0 (no) Aryl kondenserte azaplycykliske forbindelser
ATE346045T1 (de) Heteroaryl-substituierte aminocyclohexan-derivate
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
NO20043948L (no) Fremstilling av olefiner
DE60307022D1 (de) Herstellung von Organohalosilanen
DE60201466D1 (de) Einlasskrümmer
EE05234B1 (et) 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
DE60318352D1 (de) Selbstnachstellender "winner-line-up" Verstärker
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
EP1453813A4 (en) IMPROVED PURIFICATION OF 4,4- (5 -) - DI-t-BUTYL CYCLO HEXANO-18-KRONE-6
NO20021516L (no) Sko, hovedsakelig for bruk på glatt underlag
ITMI20012136A1 (it) Terapia combinata per l'ipertensione